Thrombin

Thrombin Products

  • All (6)
  • Thrombin Inhibitors (6)
  • New Thrombin Products
Catalog No. Product Name Information Product Use Citations Product Validations
S2196 Dabigatran Dabigatran is a potent nonpeptide thrombin inhibitor with an IC50 of 9.3 nM in a cell-free assay.
J Clin Invest, 2023, 133(12)e165933
Thromb Res, 2023, 227:17-24
Signal Transduct Target Ther, 2022, 7(1):59
S1346 Heparin sodium Heparin sodium, a sulfated polysaccharide belonging to the family of glycosaminoglycans, has numerous important biological activities associated with its interaction with diverse proteins. Heparin is used as an anticoagulant primarily through its interaction with AT III by enhancing AT-IIImediated inhibition of blood coagulation factors, including thrombin and factor Xa. Heparin prevents the induction of autophagy.
Ecotoxicol Environ Saf, 2023, 252:114608
STAR Protoc, 2023, 4(1):102122
Adv Sci (Weinh), 2022, 9(30):e2203388
S2154 Dabigatran (BIBR-1048) etexilate Dabigatran Etexilate (BIBR-1048) is the prodrug of dabigatran, a potent, nonpeptidic small molecule that specifically and reversibly inhibits both free and clot-bound thrombin by binding to the active site of the thrombin molecule.
Sci Rep, 2022, 12(1):3955
Malar J, 2020, 15;19(1):155
Thromb Res, 2018, 170:97-101
S2069 Argatroban (MCI-9038) Argatroban (MCI-9038) is a potent and selective synthetic thrombin inhibitor with Ki ranging from 5 nM to 39 nM, used as an anticoagulant.
Neural Regen Res, 2024, 19(2):434-439
Cancer Lett, 2023, 553:215983
J Neuroinflammation, 2022, 19(1):189
S5074 Argatroban Monohydrate Argatroban (Argatroban hydrate, Argipidine,MCI-9038 Monohydrate) is a direct, selective thrombin inhibitor with anticoagulant effects.
Cancer Lett, 2023, 553:215983
Life Sci, 2021, 269:119073
S5960 Dabigatran etexilate mesylate Dabigatran etexilate mesylate (Pradaxa, BIBR 1048MS, Dabigatran etexilate methanesulfonate) is an orally active prodrug of Dabigatran which is a reversible and selective, direct thrombin inhibitor (DTI). Dabigatran selectively and reversibly inhibits human thrombin with Ki of 4.5 nM and thrombin-induced platelet aggregation with IC50 of 10 nM.
bioRxiv, 2020, 10.1101/2020.04.22.054981
S2196 Dabigatran Dabigatran is a potent nonpeptide thrombin inhibitor with an IC50 of 9.3 nM in a cell-free assay.
J Clin Invest, 2023, 133(12)e165933
Thromb Res, 2023, 227:17-24
Signal Transduct Target Ther, 2022, 7(1):59
S1346 Heparin sodium Heparin sodium, a sulfated polysaccharide belonging to the family of glycosaminoglycans, has numerous important biological activities associated with its interaction with diverse proteins. Heparin is used as an anticoagulant primarily through its interaction with AT III by enhancing AT-IIImediated inhibition of blood coagulation factors, including thrombin and factor Xa. Heparin prevents the induction of autophagy.
Ecotoxicol Environ Saf, 2023, 252:114608
STAR Protoc, 2023, 4(1):102122
Adv Sci (Weinh), 2022, 9(30):e2203388
S2154 Dabigatran (BIBR-1048) etexilate Dabigatran Etexilate (BIBR-1048) is the prodrug of dabigatran, a potent, nonpeptidic small molecule that specifically and reversibly inhibits both free and clot-bound thrombin by binding to the active site of the thrombin molecule.
Sci Rep, 2022, 12(1):3955
Malar J, 2020, 15;19(1):155
Thromb Res, 2018, 170:97-101
S2069 Argatroban (MCI-9038) Argatroban (MCI-9038) is a potent and selective synthetic thrombin inhibitor with Ki ranging from 5 nM to 39 nM, used as an anticoagulant.
Neural Regen Res, 2024, 19(2):434-439
Cancer Lett, 2023, 553:215983
J Neuroinflammation, 2022, 19(1):189
S5074 Argatroban Monohydrate Argatroban (Argatroban hydrate, Argipidine,MCI-9038 Monohydrate) is a direct, selective thrombin inhibitor with anticoagulant effects.
Cancer Lett, 2023, 553:215983
Life Sci, 2021, 269:119073
S5960 Dabigatran etexilate mesylate Dabigatran etexilate mesylate (Pradaxa, BIBR 1048MS, Dabigatran etexilate methanesulfonate) is an orally active prodrug of Dabigatran which is a reversible and selective, direct thrombin inhibitor (DTI). Dabigatran selectively and reversibly inhibits human thrombin with Ki of 4.5 nM and thrombin-induced platelet aggregation with IC50 of 10 nM.
bioRxiv, 2020, 10.1101/2020.04.22.054981

Choose Selective Thrombin Inhibitors

Tags: Thrombin inhibitor|Thrombin agonist|Thrombin activator|Thrombin inducer|Thrombin antagonist|Thrombin signaling pathway|Thrombin assay kit